Standard Imaging continues to grow its innovative product offerings to the Medical Physics community around the world. The company has expanded its trusted QA Solutions to include a brand-new line of tissue equivalent dosimetry phantoms for stereotactic, image guidance, and medical imaging.
“Our focus is the growth and innovation of radiation QA with safety and precision always at the forefront,” said Ed Neumueller, CEO and co-founder of Standard Imaging. “Safer and more accurate patient treatments are what drive us toward greater innovation and allows us to redefine the limits of the highest-quality, safest solutions. We are excited and looking forward to introducing this new line of products to the Radiation Therapy market.”
Their recent acquisition of Integrated Medical Technologies (IMT), a global provider of radiation therapy and medical imaging phantoms for the radiotherapy and diagnostic markets, allows for an extensive suite of integrated QA solutions that include phantoms for SRS, SBRT, IGRT, SGRT, and MR Analysis.
“We’re excited to bring these phantoms into the fold of our complete integrated solutions offerings, expand upon our custom manufacturing capabilities, and extend our market segments in tissue equivalent dosimetry phantoms to better serve our customers,” said Eric DeWerd, President of Standard Imaging. “Our new phantoms complement our current products and match them in efficiency, ease of use, and reliability.”
Standard Imaging is a leading manufacturer of QA instruments for radiation-based treatments. They’ve dedicated more than 30 years to developing solutions that save you time while maintaining accurate and precise results. It’s your time. Be precise. For more information, contact our team or visit standardimaging.com